Muscle Loss and Fatty Liver Disease: A Growing Concern

A growing body of research highlights a concerning link between loss of muscle mass, known as sarcopenia and an increased risk of non-alcoholic fatty liver disease (MAFLD), including its more severe forms like cirrhosis. This connection underscores the importance of maintaining muscle health, particularly as we age, for overall liver health.

What is MAFLD and Sarcopenia?

Metabolic-associated fatty liver disease (MAFLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a condition characterized by the buildup of fat in the liver in individuals who do not consume excessive amounts of alcohol. It’s often associated with obesity, diabetes, and metabolic syndrome. MAFLD can progress to more serious conditions like non-alcoholic steatohepatitis (NASH), cirrhosis, and even liver cancer.

Sarcopenia refers to the age-related loss of skeletal muscle mass and strength. It’s a common condition affecting older adults, but can as well occur in younger individuals due to inactivity or certain medical conditions. Sarcopenia is not simply a cosmetic issue; it’s linked to increased risk of falls, disability, and mortality.

The Link Between Muscle Loss and Liver Disease

Recent studies, including research from Sichuan University published in Frontiers in Nutrition, demonstrate a significant association between sarcopenia and MAFLD. The Sichuan University study, which analyzed data from over 13,692 individuals, found that:

• Sarcopenia was 23% more common in patients with MAFLD compared to those without the condition.
• Low muscle mass was associated with a 1.58 times increased risk of developing MAFLD.
• The risk of cirrhosis doubled in individuals with low muscle mass.

The study also revealed that the combination of MAFLD and sarcopenia additively increased the risk of both mortality (aHR 1.247, 95% CI 1.132-1.373) and liver fibrosis (aOR 2.296, 95% CI 1.718-3.069 assessed by NFS score >0.676; aOR 2.218, 95% CI 1.788-2.752 assessed by FIB-4 score >1.3).

Why Does This Connection Exist?

Whereas the exact mechanisms are still being investigated, several factors may explain the link between sarcopenia and MAFLD:

• Inflammation: Both sarcopenia and MAFLD are associated with chronic low-grade inflammation, which can contribute to the progression of both conditions.
• Insulin Resistance: Sarcopenia can lead to insulin resistance, a key factor in the development of MAFLD.
• Shared Risk Factors: Conditions like obesity, diabetes, and a sedentary lifestyle increase the risk of both sarcopenia and MAFLD.

Can Muscle Loss Be Prevented or Reversed?

The good news is that muscle loss is often a modifiable risk factor. Strategies to maintain or increase muscle mass include:

• Regular Physical Activity: Both resistance training (weightlifting) and aerobic exercise are beneficial.
• Adequate Protein Intake: Consuming enough protein is essential for muscle building and repair.
• Management of Underlying Health Conditions: Controlling conditions like diabetes, high blood pressure, and lung disease can assist prevent muscle loss.

Looking Ahead

While the link between sarcopenia and MAFLD is becoming increasingly clear, further research is needed to fully understand the underlying mechanisms and to determine the most effective strategies for prevention and treatment. The Sichuan University study emphasizes the potential benefits of therapeutic strategies focused on increasing skeletal muscle mass for patients with MAFLD. Maintaining muscle health through regular exercise and a healthy diet is crucial for overall health and may play a significant role in preventing liver disease.